Comparison of autologous serum eye drops with different diluents

Current Eye Research

Volumn 38, Issue 1, 2013, Pages 9-17

  Cho, Yang Kyung ^a   Huang, Wei ^b   Kim, Geun Yeong ^a   Lim, Byung Su ^a  

^a The Catholic University of Korea   (South Korea)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Autologous serum; Concentration; Diluents; Dry eye; Persistent epithelial defect

Indexed keywords

AUTOLOGOUS SERUM EYE DROPS; CEFTAZIDIME; DILUENT; EYE DROPS; HYALEIN MINI; HYALURONIC ACID; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA DISEASE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRY EYE; FEMALE; HUMAN; MALE; PERSISTENT CORNEA EPITHELIUM DEFECT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIRMER TEST; SERRATIA INFECTION; SERRATIA MARCESCENS; SJOEGREN SYNDROME; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS WARNERI; TEAR FLOW; WOUND HEALING;

CORNEA; DRY EYE SYNDROMES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; SERUM; SJOGREN'S SYNDROME; TEARS; TREATMENT OUTCOME;

EID: 84872008264     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.720340     Document Type: Article

References (31)

1. Poon AC, Geerling G, Dart JK, Fraenkel G, Daniels J. Autologous serum eyedrops for dry eyes and epithelial defects: Clinical and in vitro toxicity studies. Br J Ophthalmol 2001;85:1188-1197
2. Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol 2007;144:86-92
3. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88:1467-1474
4. Kojima T, Higuchi A, Goto E, Matsumoto Y, Dogru M, Tsubota K. Autologous serum eye drops for the treatment of dry eye diseases. Cornea 2008;27 SUPPL 1:S25-s30
5. Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: A prospective randomized case-control study. Am J Ophthalmol 2005;139:242-246
6. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999;106:1984-1989
7. Schulze SD, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol 2006;142:207-211
8. Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 2005;243:706-714
9. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjören's syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-585
10. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615-621
11. Bron AJ. The Doyne Lecture. Reflections on the tears. Eye (Lond) 1997;11 (PT5):583-602
12. Chotikavanich S, de Paiva CS, Li de Q, Chen JJ, Bian F, Farley WJ et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 2009;50:3203-3209
13. Lemp MA. Report of the National Eye Institute/ Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221-232
14. Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88:647-652
15. Laursen AB, Fledelius H. Variations of lens thickness in relation to biomicroscopic types of human senile cataract. Acta Ophthalmol (Copenh) 1979;57:1-13
16. Lagnado R, King AJ, Donald F, Dua HS. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 2004;88:464-465
17. Tananuvat N, Daniell M, Sullivan LJ, Yi Q, McKelvie P, McCarty DJ et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001;20:802-806
18. Duch-samper AM, Capdevila C, Menezo JL, Hurtado-sarrió M. Endothelial toxicity of ceftazidime in anterior chamber irrigation solution. Exp Eye Res 1996;63:739-745
19. Lin CP, Boehnke M. Effect of fortified antibiotic solutions on corneal epithelial wound healing. Cornea 2000;19:204-206
20. Sosa AB, Epstein SP, Asbell PA. Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells. Cornea 2008;27:930-934
21. Chung SH, Lee SK, Cristol SM, Lee ES, Lee DW, Seo KY et al. Impact of short-Term exposure of commercial eyedrops preserved with benzalkonium chloride on precorneal mucin. Mol Vis 2006;12:415-421
22. Epstein SP, Ahdoot M, Marcus E, Asbell PA. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther 2009;25:113-119
23. Yanochko GM, Khoh-Reiter S, Evans MG, Jessen BA. Comparison of preservative-induced toxicity on monolayer and stratified Chang conjunctival cells. Toxicol In Vitro 2010;24:1324-1331
24. Eriksson P, Andersson C, Ekerfelt C, Ernerudh J, Skogh T. Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjören's syndrome, rheumatoid arthritis and healthy controls. Clin Exp Immunol 2004;137:617-620
25. Mieliauskaite D, Venalis P, Dumalakiene I, Venalis A, Distler J. Relationship between serum levels of TGF-beta1 and clinical parameters in patients with rheumatoid arthritis and Sjören's syndrome secondary to rheumatoid arthritis. Autoimmunity 2009;42:356-358
26. Gomes JA, Amankwah R, Powell-Richards A, Dua HS. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 2004;88:821-825
27. Shimmura S, Ono M, Shinozaki K, Toda I, Takamura E, Mashima Y et al. Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol 1995;79:1007-1011
28. Aragona P, Papa V, Micali A, Santocono M, Milazzo. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002;86:181-184
29. Camillieri G, Bucolo C, Rossi S, Drago F. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect. J Ocul Pharmacol Ther 2004;20:548-553
30. Liu L, Tiffany J, Dang Z, Dart JK, Watson SL, Daniels JT et al. Nourish and nurture: Development of a nutrient ocular lubricant. Invest Ophthalmol Vis Sci 2009;50:2932-2939
31. Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Kasper K et al. Corneal epitheliotrophic capacity of three different blood-derived preparations. Invest Ophthalmol Vis Sci 2006;47:2438-2444